These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


343 related items for PubMed ID: 15579770

  • 1. Thyrotropin (TSH)-induced production of vascular endothelial growth factor in thyroid cancer cells in vitro: evaluation of TSH signal transduction and of angiogenesis-stimulating growth factors.
    Hoffmann S, Hofbauer LC, Scharrenbach V, Wunderlich A, Hassan I, Lingelbach S, Zielke A.
    J Clin Endocrinol Metab; 2004 Dec; 89(12):6139-45. PubMed ID: 15579770
    [Abstract] [Full Text] [Related]

  • 2. Functional thyrotropin receptor attenuates malignant phenotype of follicular thyroid cancer cells.
    Hoffmann S, Maschuw K, Hassan I, Wunderlich A, Lingelbach S, Ramaswamy A, Hofbauer LC, Zielke A.
    Endocrine; 2006 Aug; 30(1):129-38. PubMed ID: 17185801
    [Abstract] [Full Text] [Related]

  • 3. Mutual antagonistic interactions between the thyrotropin (adenosine 3',5'-monophosphate) and protein kinase C/epidermal growth factor (tyrosine kinase) pathways in cell proliferation and differentiation of cultured human thyroid follicles.
    Kraiem Z, Sadeh O, Yosef M, Aharon A.
    Endocrinology; 1995 Feb; 136(2):585-90. PubMed ID: 7835292
    [Abstract] [Full Text] [Related]

  • 4. TSH induces metallothionein 1 in thyrocytes via Gq/11- and PKC-dependent signaling.
    Bäck CM, Stohr S, Schäfer EA, Biebermann H, Boekhoff I, Breit A, Gudermann T, Büch TR.
    J Mol Endocrinol; 2013 Feb; 51(1):79-90. PubMed ID: 23613280
    [Abstract] [Full Text] [Related]

  • 5. Suppression of thyrotropin receptor-G protein-phospholipase C coupling by activation of protein kinase C in thyroid carcinoma cells.
    Broecker M, Mayr GW, Derwahl M.
    Endocrinology; 1997 Sep; 138(9):3787-96. PubMed ID: 9275066
    [Abstract] [Full Text] [Related]

  • 6. Thyrotropin stimulates invasion and growth of follicular thyroid cancer cells via PKC- rather than PKA-activation.
    Hoelting T, Tezelman S, Siperstein AE, Duh QY, Clark OH.
    Biochem Biophys Res Commun; 1993 Sep 30; 195(3):1230-6. PubMed ID: 8216254
    [Abstract] [Full Text] [Related]

  • 7. Interaction of human chorionic gonadotropin (hCG) and asialo-hCG with recombinant human thyrotropin receptor.
    Hoermann R, Broecker M, Grossmann M, Mann K, Derwahl M.
    J Clin Endocrinol Metab; 1994 Apr 30; 78(4):933-8. PubMed ID: 8157724
    [Abstract] [Full Text] [Related]

  • 8. Proangiogenic effect of TSH in human microvascular endothelial cells through its membrane receptor.
    Balzan S, Del Carratore R, Nicolini G, Beffy P, Lubrano V, Forini F, Iervasi G.
    J Clin Endocrinol Metab; 2012 May 30; 97(5):1763-70. PubMed ID: 22419707
    [Abstract] [Full Text] [Related]

  • 9. Expression of the human TSH receptor in a human thyroid carcinoma cell line that lacks an endogenous TSH receptor: growth inhibition by cAMP.
    Derwahl M, Kuemmel M, Goretzki P, Schatz H, Broecker M.
    Biochem Biophys Res Commun; 1993 Mar 31; 191(3):1131-8. PubMed ID: 8385451
    [Abstract] [Full Text] [Related]

  • 10. Thyroid-stimulating hormone promotes the secretion of vascular endothelial growth factor in thyroid cancer cell lines.
    Soh EY, Sobhi SA, Wong MG, Meng YG, Siperstein AE, Clark OH, Duh QY.
    Surgery; 1996 Dec 31; 120(6):944-7. PubMed ID: 8957478
    [Abstract] [Full Text] [Related]

  • 11. Interactions between sphingosine-1-phosphate and vascular endothelial growth factor signalling in ML-1 follicular thyroid carcinoma cells.
    Balthasar S, Bergelin N, Löf C, Vainio M, Andersson S, Törnquist K.
    Endocr Relat Cancer; 2008 Jun 31; 15(2):521-34. PubMed ID: 18509004
    [Abstract] [Full Text] [Related]

  • 12. The protein kinase A pathway inhibits c-jun and c-fos protooncogene expression induced by the protein kinase C and tyrosine kinase pathways in cultured human thyroid follicles.
    Heinrich R, Kraiem Z.
    J Clin Endocrinol Metab; 1997 Jun 31; 82(6):1839-44. PubMed ID: 9177393
    [Abstract] [Full Text] [Related]

  • 13. Stimulation by thyroid-stimulating hormone and Grave's immunoglobulin G of vascular endothelial growth factor mRNA expression in human thyroid follicles in vitro and flt mRNA expression in the rat thyroid in vivo.
    Sato K, Yamazaki K, Shizume K, Kanaji Y, Obara T, Ohsumi K, Demura H, Yamaguchi S, Shibuya M.
    J Clin Invest; 1995 Sep 31; 96(3):1295-302. PubMed ID: 7657804
    [Abstract] [Full Text] [Related]

  • 14. Thyrotropin (TSH) receptor antibodies (TSHrAb) can inhibit TSH-mediated cyclic adenosine 3',5'- monophosphate production in thyroid cells by either blocking TSH binding or affecting a step subsequent to TSH binding.
    Dallas JS, Cunningham SJ, Patibandla SA, Seetharamaiah GS, Morris JC, Tahara K, Kohn LD, Prabhakar BS.
    Endocrinology; 1996 Aug 31; 137(8):3329-39. PubMed ID: 8754759
    [Abstract] [Full Text] [Related]

  • 15. Similar and divergent patterns in the regulation of matrix metalloproteinase-1 (MMP-1) and tissue inhibitor of MMP-1 gene expression in benign and malignant human thyroid cells.
    Korem S, Resnick MB, Kraiem Z.
    J Clin Endocrinol Metab; 1999 Sep 31; 84(9):3322-7. PubMed ID: 10487706
    [Abstract] [Full Text] [Related]

  • 16. Expression and secretion of endostatin in thyroid cancer.
    Hoffmann S, Wunderlich A, Lingelbach S, Musholt PB, Musholt TJ, von Wasielewski R, Zielke A.
    Ann Surg Oncol; 2008 Dec 31; 15(12):3601-8. PubMed ID: 18818971
    [Abstract] [Full Text] [Related]

  • 17. Immunohistochemical expression of growth factors in subacute thyroiditis and their effects on thyroid folliculogenesis and angiogenesis in collagen gel matrix culture.
    Toda S, Nishimura T, Yamada S, Koike N, Yonemitsu N, Watanabe K, Matsumura S, Gärtner R, Sugihara H.
    J Pathol; 1999 Aug 31; 188(4):415-22. PubMed ID: 10440753
    [Abstract] [Full Text] [Related]

  • 18. Serum vascular endothelial growth factor levels are elevated in metastatic differentiated thyroid cancer but not increased by short-term TSH stimulation.
    Tuttle RM, Fleisher M, Francis GL, Robbins RJ.
    J Clin Endocrinol Metab; 2002 Apr 31; 87(4):1737-42. PubMed ID: 11932308
    [Abstract] [Full Text] [Related]

  • 19. Substitutions of different regions of the third cytoplasmic loop of the thyrotropin (TSH) receptor have selective effects on constitutive, TSH-, and TSH receptor autoantibody-stimulated phosphoinositide and 3',5'-cyclic adenosine monophosphate signal generation.
    Kosugi S, Okajima F, Ban T, Hidaka A, Shenker A, Kohn LD.
    Mol Endocrinol; 1993 Aug 31; 7(8):1009-20. PubMed ID: 7901757
    [Abstract] [Full Text] [Related]

  • 20. Different expression of TSH receptor and NIS genes in thyroid cancer: role of epigenetics.
    D'Agostino M, Sponziello M, Puppin C, Celano M, Maggisano V, Baldan F, Biffoni M, Bulotta S, Durante C, Filetti S, Damante G, Russo D.
    J Mol Endocrinol; 2014 Apr 31; 52(2):121-31. PubMed ID: 24353283
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 18.